Analysed ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) News Sources
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
17-04-2026
yahoo.com
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum
21-04-2026
yahoo.com
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors
28-04-2026
yahoo.com
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
05-05-2026
yahoo.com
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
13-05-2026
yahoo.com
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
15-05-2026
yahoo.com
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003
19-05-2026
yahoo.com
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
02-06-2026
yahoo.com
What is the current price of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)?
The current price of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) is $1.36.
ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) since the previous trading day is $-0.01.
ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) since the previous trading day is -0.7299%.
What is the most recent average sentiment score for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)?
The most recent average sentiment score for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)?
The most recent sentiment for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) is .
SEC-8K** Filing Available For ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.